Skip to main content

Table 2 Biochemical analysis of serum samples of C. mrigala

From: Biopreservative efficacy of Enterococcus faecium-immobilised film and its enterocin against Salmonella enterica

Group

SGPT U/L

SGOT U/L

ALP U/L

T. Billuribin mg/dl

D. Bilirubin mg/dl

Protein g/dl

Urea mg/dl

Creatinine mg/dl

Albumin g/dl

UT

7.3 ± 0.95

76 ± 6.24

97.33 ± 3.50

3.1 ± 0.2

0.73 ± 0.15

2.66 ± 0.57

12.36 ± 1.75

0.26 ± 0.025

0.93 ± 0.152

VC

7.4 ± 0.99 (+ 1.36%)

76.65 ± 3.5 (+ 0.85%)

96.33 ± 3.20 (− 1.02%)

2.9 ± 0.4 (− 6.45%)

0.95 ± 0.22 (+ 30%)

2.33 ± 0.29 (− 12%)

12.66 ± 1.10 (+ 12.42%)

0.26 ± 0.011 (0%)

0.90 ± 0.1 (− 3.22%)

ESmr18

7.52 ± 1.0 (+ 3.01%)

73.63 ± 4.5 (− 3.11%)

97.66 ± 6.65 (+ 0.33%)

2.8 ± 0.55 (− 9.6%)

0.73 ± 0.15 (0%)

2.23 ± 0.30 (− 16.16%)

13.4 ± 0.65 (+ 8.41%)

0.24 ± 0.005 (− 7.69%)

1.03 ± 0.057 (+ 10.75)

  1. Data expressed as mean ± S.D. (n = 6). UT: Untreated healthy control; VC: vehicle control; ESmr18: crude ESmr18 treated. Values in parenthesis are percent change over control
  2. − indicates decrease over control
  3. + indicates increase over control